XENETIC BIOSCIENCES INC
XBIONASDAQ🏆 #3825 by market capUS Equity
$69.63▲ $0.05 (+0.07%)
Simulated price1h—
24h▲ 0.1%
7d▲ 2292.8%
14d▲ 2537.5%
30d▲ 2459.9%
1y▲ 2459.9%
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
+23.5%
Healthy
📊Gross Margin
98.7%
High
💵FCF Margin
159.9%
Strong
⚖️P/S Ratio
2.3x
Cheap
Otter Score
53
Weak
Trading Snapshot
- Day Range
- $68.72 – $70.07
- 52-Week Range
- $1.90 – $13.93
- Volume
- $2.03B
- Avg Volume
- $1.66B
- Shares Outstanding
- 2.3M
- Next Earnings
- Sep 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $595,309
- P/E Ratio
- —
- P/S Ratio
- 2.3x
- EPS (TTM)
- $-1.24
- Dividend Yield
- —
Why Investors Own XBIO
- ✓High-growth profile — revenue up +25.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 61% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$3M▲ +24.5% YoY
Gross Margin (TTM)
60.8%▲ +2.1% YoY
Operating Income (TTM)
$728,525▲ +24.5% YoY
Free Cash Flow (TTM)
$695,177▲ +24.5% YoY
About XENETIC BIOSCIENCES INC
A company profile for XENETIC BIOSCIENCES INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
53/100
Analyst Ratings
ⓘConsensus
Sell
6 analysts
Strong Buy0
Buy0
Hold3
Sell1
Strong Sell2
Ratings as of Feb 2026